Market Overview - The medical beauty sector experienced a decline of 1.41% on January 27, with *ST Meigu leading the drop [1] - The Shanghai Composite Index closed at 4139.9, up 0.18%, while the Shenzhen Component Index closed at 14329.91, up 0.09% [1] Individual Stock Performance - Aimei Ke (300896) closed at 140.31, down 1.20% with a trading volume of 31,300 shares and a transaction value of 439 million [1] - Jinbo Biological (920982) closed at 228.34, down 1.31% with a trading volume of 5,531 shares and a transaction value of 127 million [1] - Huaxi Biological (688363) closed at 46.43, down 1.59% with a trading volume of 49,700 shares and a transaction value of 229 million [1] - *ST Meigu (000615) closed at 3.19, down 2.15% with a trading volume of 108,900 shares and a transaction value of 34.8 million [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 41.32 million from main funds and a net outflow of 3.13 million from speculative funds, while retail investors had a net inflow of 44.45 million [1] - For *ST Meigu, the main funds had a net outflow of 9.71 million, accounting for -27.91% of the total, while retail investors had a net inflow of 7.40 million, representing 21.26% [2] - Huaxi Biological experienced a net outflow of 14.32 million from main funds, with a net inflow of 4.64 million from retail investors [2] - Aimei Ke had a net outflow of 17.28 million from main funds, with a net inflow of 32.41 million from retail investors [2] - Jinbo Biological saw a net outflow of 19.33 million from main funds, with a net outflow of 188,440 from retail investors [2]

证券代码：000615 证券简称：*ST美谷 公告编号：2026-016 奥园美谷科技股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 重要提示： 1、本次股东会无否决提案的情形； 2、本次股东会不涉及变更以往股东会已通过决议的情形。 一、会议的召开情况 1、会议召开时间： （1）现场会议时间：2026 年 1 月 26 日（星期一）下午 15:30 开始； （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为 2026 年 1 月 26 日的交易时间，即上午 9:15-9:25，9:30-11:30，下午 13:00-15:00； 通过深圳证券交易所互联网投票系统进行网络投票的时间为 2026 年 1 月 26 日上 午 9:15 至下午 15:00 间的任意时间。 2、现场会议召开地点：广东省广州市天河区黄埔大道西 108 号 6、股权登记日：2026 年 1 月 20 日 7、本次股东会会议召开符合有关法律、行政法规及部门规章、规范性文件 和《公司章程》的有关规定。 二、会议的出席情况 中小 ...

关于奥园美谷科技股份有限公司 2026年第一次临时股东会的 法律意见书 关于奥园美谷科技股份有限公司 2026年第一次临时股东会的法律意见书 君達律師事務所 aw Hirm 广东广信君达律师事务所 (2026) 广信君达律见字第 117786-8 号 致:奥园美谷科技股份有限公司 广东广信君达律师事务所(以下简称"本所")接受奥园美谷科技股份有 限公司（以下简称"公司"）的委托，指派杨尹、吴震宇律师（以下简称"本 所律师"）出席公司 2026年第一次临时股东会（以下简称"本次股东会"）, 并获授权依据 《中华人民共和国公司法》(以下简称《公司法》)、《中华人 民共和国证券法》、《上市公司股东会规则》（以下简称《股东会规则》）、 《深圳证券交易所上市公司股东会网络投票实施细则（2025年修订）》（以下 简称《网络投票实施细则》）和《奥园美谷科技股份有限公司章程》（以下简 称《公司章程》）的有关规定出具本法律意见书。 为出具本法律意见,本所律师参加了本次股东会,并审慎查阅了公司提供 的以及本所律师认为必要的与本次股东会有关的文件资料。本所律师已获公司 作出如下承诺与保证:公司向本所律师提供的文件、资料或信息(含文 ...

Group 1 - The medical beauty sector experienced a slight decline of 0.03% on January 26, with *ST Meigu leading the drop [1] - The Shanghai Composite Index closed at 4132.61, down 0.09%, while the Shenzhen Component Index closed at 14316.64, down 0.85% [1] - Key stocks in the medical beauty sector showed mixed performance, with Huaxi Biological up 1.03% and *ST Meigu down 1.81% [1] Group 2 - The medical beauty sector saw a net outflow of 14.71 million yuan from main funds, while retail investors contributed a net inflow of 8.53 million yuan [1] - Detailed fund flow data indicates that Huaxi Biological had a main fund net inflow of 5.91 million yuan, while *ST Meigu experienced a significant main fund net outflow of 7.46 million yuan [2] - Retail investors showed a positive net inflow in several stocks, with Love Beauty seeing a retail net inflow of 26.41 million yuan despite a main fund outflow [2]

Core Viewpoint - The medical beauty sector experienced a decline of 1.35% on January 22, with Jinbo Biological leading the drop, while the overall market indices showed slight increases [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4122.58, up 0.14% - The Shenzhen Component Index closed at 14327.05, up 0.5% [1]. Group 2: Individual Stock Performance - ST Meigu closed at 3.34, with an increase of 1.52% and a trading volume of 60,900 shares, totaling a transaction value of 20.15 million yuan - Huaxi Biological closed at 45.54, down 0.76% with a trading volume of 28,800 shares, totaling a transaction value of 13.2 million yuan - Aimeike closed at 141.60, down 2.07% with a trading volume of 31,200 shares, totaling a transaction value of 44.6 million yuan - Jinbo Biological closed at 226.99, down 2.21% with a trading volume of 7,993.54 shares, totaling a transaction value of 183 million yuan [1]. Group 3: Capital Flow Analysis - The medical beauty sector saw a net outflow of 66.31 million yuan from main funds, while retail investors contributed a net inflow of 45.07 million yuan - The detailed capital flow for individual stocks shows: - ST Meigu: Main funds net inflow of 1.81 million yuan, retail net outflow of 759,000 yuan - Huaxi Biological: Main funds net outflow of 24.14 million yuan, retail net inflow of 8.44 million yuan - Jinbo Biological: Main funds net outflow of 35.10 million yuan, retail net inflow of 313,600 yuan - Aimeike: Main funds net outflow of 43.98 million yuan, retail net inflow of 37.39 million yuan [2].

Core Viewpoint - *ST Meigu (000615.SZ) has received approval from the Shenzhen Stock Exchange to revoke the delisting risk warning due to restructuring, effective January 22, 2026. However, the company will continue to face delisting risk warnings due to negative net assets for the fiscal year 2024 and ongoing financial uncertainties [1] Group 1 - The delisting risk warning related to the court's acceptance of the restructuring has been revoked [1] - The company's stock will still be subject to delisting risk warnings due to negative net assets post-2024 audit [1] - The company has faced continuous negative net profits for three consecutive years from 2022 to 2024, leading to additional risk warnings [1] Group 2 - The company's main bank accounts have been frozen due to litigation, contributing to ongoing uncertainties regarding its ability to continue operations [1] - The stock will retain the designation "*ST Meigu" and the trading code "000615" [1] - The daily price fluctuation limit for the stock remains at 5% [1]

证券代码：000615 证券简称：*ST美谷 公告编号：2026-015 奥园美谷科技股份有限公司 关于撤销公司股票因重整而被实施退市风险警示暨继续被 实施退市风险警示及其他风险警示的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、奥园美谷科技股份有限公司（以下简称"公司"）重整计划已执行完毕， 根据《深圳证券交易所股票上市规则》（以下简称《股票上市规则》）等相关 规定，公司股票因被法院裁定受理重整而触及的退市风险警示情形已经消除， 公司已向深圳证券交易所（以下简称"深交所"）申请撤销因被法院裁定受理 重整而触及的退市风险警示情形。 2、2026 年 1 月 21 日，深交所经审核同意公司撤销因重整而实施的退市风 险警示，公司股票交易将自 2026 年 1 月 22 日起撤销因重整而实施的退市风险 警示。 相关规定，公司股票交易自 2025 年 11 月 17 日起被叠加实施退市风险警示。具 体内容详见公司于 2025 年 11 月 15 日披露在（www.cninfo.com.cn，下同）的《关 于法院裁定受理公司重整并指定管理人暨公司 ...

Group 1 - The medical beauty sector increased by 0.06% compared to the previous trading day, with *ST Meigu leading the gains [1] - The Shanghai Composite Index closed at 4116.94, up by 0.08%, while the Shenzhen Component Index closed at 14255.12, up by 0.7% [1] - The net outflow of main funds in the medical beauty sector was 55.1474 million yuan, while retail investors saw a net inflow of 66.2404 million yuan [1] Group 2 - The net outflow from speculative funds was 11.093 million yuan [1] - A detailed table of individual stock fund flows in the medical beauty sector was provided [1]

Market Overview - The medical beauty sector experienced a decline of 1.35% on January 20, with *ST Meigu leading the drop [1] - The Shanghai Composite Index closed at 4113.65, down 0.01%, while the Shenzhen Component Index closed at 14155.63, down 0.97% [1] Stock Performance - Key stocks in the medical beauty sector showed the following performance: - Huaxi Biological (688363) closed at 45.82, down 0.82% with a trading volume of 35,000 shares and a turnover of 161 million yuan [1] - Aimeike (300896) closed at 144.82, down 1.59% with a trading volume of 30,000 shares and a turnover of 436 million yuan [1] - Jinbo Biological (920982) closed at 234.11, down 1.96% with a trading volume of 6,327 shares and a turnover of 149 million yuan [1] - *ST Meigu (000615) closed at 3.24, down 2.70% with a trading volume of 106,900 shares and a turnover of 34.95 million yuan [1] Capital Flow - The medical beauty sector saw a net outflow of 100 million yuan from main funds, while retail investors contributed a net inflow of 74.88 million yuan [1] - Detailed capital flow for key stocks includes: - *ST Meigu: Main funds net outflow of 11.12 million yuan, retail net inflow of 6.93 million yuan [2] - Jinbo Biological: Main funds net outflow of 25.90 million yuan, retail net outflow of 1.30 million yuan [2] - Huaxi Biological: Main funds net outflow of 31.89 million yuan, retail net inflow of 22.38 million yuan [2] - Aimeike: Main funds net outflow of 57.26 million yuan, retail net inflow of 45.57 million yuan [2]

Group 1 - The A-share market is experiencing short-term fluctuations due to a cooling of investor sentiment, but the overall bull market pattern remains unchanged [1][7] - The market is entering a low volatility phase, with speculative sentiment decreasing, yet small-cap stocks are leading the gains and financing balances continue to rise, indicating that funds are still seeking flexibility [7] - Short-term market sentiment is still relatively high, and if there are catalysts in fundamentals or liquidity, the overall trend of A-shares may move upward [7] Group 2 - The Supreme People's Procuratorate has made deployments to utilize legal power to serve high-quality development, emphasizing the need to maintain economic and financial security and to combat serious economic crimes [4] - The China Securities Regulatory Commission (CSRC) has imposed a three-year market ban on Jin Yongrong for illegal stock recommendations and reverse trading, highlighting regulatory actions against market manipulation [5] - Several companies are facing significant financial challenges, with projected losses for 2025 including Tianhe Solar with a net profit loss of 6.5 billion to 7.5 billion yuan and other firms like Water Well and Yatai Group also expecting substantial losses [6]